Documentos relacionados

1. A pilot study of orelabrutinib treatment in three cases of refractory/relapsed autoimmune haemolytic anaemia/Evans syndrome.
2. [Cold agglutinin disease: pathology, diagnosis, and treatment].
3. Possible role of IL-23 inhibitor in autoimmune hemolytic anemia.
4. Determinants of long-term outcomes of splenectomy in pediatric autoimmune cytopenias.
5. Long term follow-up of pediatric-onset Evans syndrome: broad immunopathological manifestations and high treatment burden.
6. Fostamatinib for warm antibody autoimmune hemolytic anemia: Phase 3, randomized, double-blind, placebo-controlled, global study (FORWARD).
7. Ultrastructural analysis of nucleated erythrocyte in patients with autoimmune hemolytic anemia (AIHA).
8. Outcomes of therapeutic plasma exchange in severe autoimmune hemolytic anemia hospitalizations: An analysis of the National Inpatient Sample.
9. Survival in autoimmune hemolytic anemia remains poor, results from a nationwide cohort with 37 years of follow-up.
10. A Rare Case of Autoimmune Hemolytic Anemia Caused by Autoantibody with Mimicking Anti-D and Anti-C Specificity.